The AFP-Alpha Feto Protein Test is a vital component of the Hepatic Tumor Markers package.

This test measures the levels of AFP in the blood, which is a protein produced by the liver and yolk sac during fetal development.

Elevated levels of AFP in adults can indicate the presence of liver tumors, particularly hepatocellular carcinoma (HCC).

Regular monitoring of AFP levels can help in the early detection of liver cancer and assessing the effectiveness of treatment.

The AFP-Alpha Feto Protein Test is an important tool for both diagnosis and monitoring of liver tumors.

The Carcino Embryonic Antigen-CEA test is another significant test included in the Hepatic Tumor Markers package.

CEA is a protein that is commonly found in the blood of people with certain types of cancers, including liver cancer. Monitoring CEA levels can provide valuable information about the presence and progression of liver tumors.

1. Elevated CEA levels may indicate the need for further diagnostic tests or the need for close monitoring of the tumor.
2. The CEA test is a valuable tool in the management and surveillance of liver tumors.

The Hepatic Tumor Markers test package specifically targets the diagnosis of liver cancer and related conditions. The AFP-Alpha Feto Protein Test is a vital component of this package as it helps in detecting and monitoring liver cancer. Elevated levels of AFP may indicate the presence of liver cancer or other liver diseases.

Carcino Embryonic Antigen-CEA test is also included, which can be helpful in diagnosing liver cancer, as well as other types of cancer such as colorectal and lung cancer. By analyzing the levels of these tumor markers, healthcare professionals can assess the risk and progression of liver cancer and guide appropriate treatment decisions.

The Hepatic Tumor Markers test package consists of two primary tests - the AFP-Alpha Feto Protein Test and Carcino Embryonic Antigen-CEA test.

The AFP-Alpha Feto Protein Test measures the levels of AFP in the blood, which is a protein produced by the developing liver of a fetus. Elevated levels of AFP in adults can indicate liver cancer or other liver diseases.

The Carcino Embryonic Antigen-CEA test measures the levels of CEA, a protein that can be elevated in various types of cancer, including liver cancer.

These tests provide crucial information about the presence and progression of liver cancer, enabling timely intervention and appropriate treatment.

If you are experiencing certain symptoms, it is advisable to consider the Hepatic Tumor Markers test package.

Symptoms that may indicate the need for this package include:

1. Unexplained weight loss
2. Persistent abdominal pain
3. Jaundice (yellowing of the skin and eyes)
4. Loss of appetite
5. Fatigue
6. Enlarged liver or spleen

These symptoms can be indicative of liver cancer or other liver-related conditions. However, it is important to note that these symptoms can also be caused by other factors, and the test package helps in providing a more accurate diagnosis.

If you are experiencing any of these symptoms or have a higher risk of liver cancer, consulting with a healthcare professional and considering the Hepatic Tumor Markers test package can provide valuable insights into your liver health.

At Pathofast Lab, we prioritize your health and safety.

Our lab is equipped with state-of-the-art facilities and follows strict cleanliness protocols to ensure a safe and hygienic environment for all patients.

We regularly sanitize our equipment and maintain a clean workspace to minimize the risk of contamination.

Our dedicated team of medical professionals takes utmost care to ensure that your samples are handled with precision and accuracy.

Trust Pathofast Lab for a safe and clean testing experience that puts your well-being first.

We understand that visiting a lab for sample collection can be inconvenient, especially if you have a busy schedule or limited mobility.

At Pathofast Lab, we offer a convenient solution - free home visits for sample collection. Our trained professionals will come to your doorstep at a time that suits you best, ensuring a hassle-free and comfortable experience.

Say goodbye to the inconvenience of traveling to a lab and let us bring the lab to you. Choose Pathofast Lab for convenient and reliable sample collection services.

At Pathofast Lab, we utilize the power of Artificial Intelligence (AI) to provide you with comprehensive explanations of your lab reports.

Our advanced AI algorithms analyze your test results and generate detailed insights, making it easier for you to understand your health status.

With AI-powered explanations, you can gain valuable knowledge about your conditions, potential risks, and recommended actions.

Trust Pathofast Lab for accurate and easily understandable lab reports, backed by the latest technology and medical expertise.

If you have recently been diagnosed with liver cancer, the Hepatic Tumor Markers Package is essential for monitoring your condition.

Regularly monitoring tumor markers such as AFP-Alpha Feto Protein and Carcino Embryonic Antigen-CEA is crucial in assessing the progression of the disease.

This package provides accurate and reliable results, enabling your healthcare provider to determine the effectiveness of your treatment plan and make necessary adjustments.

By keeping a close watch on these tumor markers, you can actively participate in your treatment journey and improve your chances of successful recovery.

Stay proactive and opt for the Hepatic Tumor Markers Package for post-diagnosis monitoring.

Individuals at a high risk of developing liver cancer can benefit greatly from the Hepatic Tumor Markers Package.

If you have a family history of liver cancer, chronic liver disease, or have been exposed to risk factors such as hepatitis B or C, this package is recommended.

Regular screening using the AFP-Alpha Feto Protein Test and Carcino Embryonic Antigen-CEA test can help detect liver tumors at an early stage, when treatment options are most effective.

By opting for this package, you can take proactive steps towards preventing liver cancer and ensuring early intervention if necessary.

Safeguard your health and choose the Hepatic Tumor Markers Package if you fall under the high-risk category.

For individuals undergoing treatment for liver cancer, monitoring the effectiveness of the treatment is crucial.

The Hepatic Tumor Markers Package offers regular assessment of tumor markers AFP-Alpha Feto Protein and Carcino Embryonic Antigen-CEA to evaluate the progress of the treatment.

By tracking these markers, your healthcare provider can make informed decisions about the course of your treatment and make adjustments if needed.

Regular monitoring helps ensure that the treatment is working effectively and allows for timely modifications if required.

If you are currently undergoing treatment for liver cancer, consider the Hepatic Tumor Markers Package to monitor the effectiveness of your therapy.